NFL BIOSCIENCES (EPA:ALNFL) | WebDisclosure

Basculer en Français

11062	Companies
242639	Keywords
170878	Articles
130596	Press releases

Home
Companies
NFL BIOSCIENCES

REGULATED PRESS RELEASE

published on 03/29/2024 at 17:45, 2 years 5 months ago

NFL BIOSCIENCES: 2023 FULL-YEAR BUSINESS AND EARNINGS UPDATE
BRIEF

published on 03/11/2024 at 09:00, 2 years 6 months ago

NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP

NFL Biosciences PORTZAMPARC BNP Paribas Biopharmaceutical Industry Analyst Coverage
BRIEF

published on 03/11/2024 at 09:00, 2 years 6 months ago

NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS

Marché Financier NFL Biosciences PORTZAMPARC BNP Paribas Couverture Analyste
REGULATED PRESS RELEASE

published on 03/11/2024 at 08:55, 2 years 6 months ago

NFL BIOSCIENCES: INITIATION OF ANALYST COVERAGE BY PORTZAMPARC - BNP PARIBAS GROUP
REGULATED PRESS RELEASE

published on 03/11/2024 at 08:55, 2 years 6 months ago

NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR PORTZAMPARC – GROUPE BNP PARIBAS
ARTICLE

published on 02/13/2024 at 18:45, 2 years 7 months ago

NFL BIOSCIENCES ANNONCE SA PARTICIPATION AU CONGRÈS DE LA SRNT
Présentation des résultats prometteurs de l'étude PRECESTO dans la lutte contre le tabagisme

NFL Biosciences Innovation NFL-101 Tabagisme SRNT
REGULATED PRESS RELEASE

published on 02/13/2024 at 17:45, 2 years 7 months ago

NFL BIOSCIENCES WILL PRESENT THE RESULTS OF THE PRECESTO CLINICAL STUDY AT THE SRNT CONFERENCE, THE WORLD'S LEADING SCIENTIFIC SOCIETY IN THE FIELD OF NICOTINE AND TOBACCO RESEARCH
NFL Biosciences to present promising results of the PRECESTO clinical study at the SRNT Conference, focusing on smoking cessation with botanical drug NFL-101. Phase 2b trial ongoing for CESTO 2

NFL Biosciences Smoking Cessation NFL-101 PRECESTO Study CESTO 2
REGULATED PRESS RELEASE

published on 02/13/2024 at 17:45, 2 years 7 months ago

NFL BIOSCIENCES PRÉSENTERA LES RÉSULTATS DE L’ÉTUDE PRECESTO LORS DU CONGRÈS DE LA SRNT, LA SOCIÉTÉ SCIENTIFIQUE DE RÉFÉRENCE AU NIVEAU MONDIAL DANS LA LUTTE CONTRE LE TABAGISME
NFL Biosciences présentera les résultats de l'étude PRECESTO lors du congrès de la SRNT à Édimbourg le 20-23 mars 2024, montrant l'efficacité de NFL-101 dans la réduction de la satisfaction de fumer

NFL Biosciences NFL-101 Étude PRECESTO Tabagisme SRNT
REGULATED PRESS RELEASE

published on 01/30/2024 at 08:00, 2 years 7 months ago

NFL BIOSCIENCES: SUCCESS OF THE STUDY WITH THE CEA
NFL BIOSCIENCES announces the successful study with the CEA demonstrating a new mechanism of action for smoking cessation using NFL-101, a botanical drug. Results open new possibilities for addiction treatment

NFL Biosciences Addiction Treatment CEA Study Smoking Cessation NFL-101
REGULATED PRESS RELEASE

published on 01/30/2024 at 08:00, 2 years 7 months ago

NFL BIOSCIENCES : SUCCÈS DE L’ÉTUDE AVEC LE CEA
NFL BIOSCIENCES annonce la mise en ubrique, étude d'imagerie moléculaire menée par le CEA, du mécanisme d'action innovant du candidat médicament NFL-101 pour le sevrage tabagique

NFL Biosciences Étude D'imagerie Moléculaire Sevrage Tabagique CEA Mécanisme D'action

Accesswire

Published on 09/23/2026 at 15:42, 1 hour 58 minutes ago

Global Atomic Announces C$50 Million Public Offering of Units
Published on 09/23/2026 at 14:31, 3 hours 9 minutes ago

First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/23/2026 at 14:30, 3 hours 10 minutes ago

Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
Published on 09/23/2026 at 14:00, 3 hours 40 minutes ago

Integrated Rewards Launches "Celebrate Canadian" Campaign to Connect Canadian Brands with Millions of Consumers
Published on 09/23/2026 at 13:30, 4 hours 10 minutes ago

Engineering Cost Study Validates Commercial-Scale U.S. HPMSM Capital Cost and Establishes EMM Capital Cost for Electric Metals' North Star Manganese Project

View all ACCESSWIRE

EQS Group

Published on 09/23/2026 at 17:30, 10 minutes ago

Disclosure of significant holding of Reinet Investments S.C.A. shares
Published on 09/23/2026 at 16:55, 45 minutes ago

Bird.com secures $450m financing as it launches communications infrastructure for AI agents
Published on 09/23/2026 at 16:40, 1 hour ago

Xryma Plc Goes Live on the ECB T2 Real-Time Gross Settlement Network
Published on 09/23/2026 at 16:30, 1 hour 10 minutes ago

nobilia and Coohom Forge Strategic Global Partnership to Redefine the Future of Kitchen Planning with Spatial Intelligence
Published on 09/23/2026 at 15:42, 1 hour 57 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

Les Echos

Published on 09/23/2026 at 17:20, 19 minutes ago

260923 BENETEAU Results H1 2026
Published on 09/23/2026 at 17:20, 19 minutes ago

260923 BENETEAU Résultats S1 2026
Published on 09/23/2026 at 17:19, 20 minutes ago

260923 BENETEAU Results H1 2026 presentation
Published on 09/23/2026 at 17:19, 20 minutes ago

260923 BENETEAU Résultats S1 2026 présentation
Published on 09/23/2026 at 08:00, 9 hours 40 minutes ago

Résultats semestriels 2026 - ANR par action : 101,90 €, en progression de 8,18 % - Capitaux propres consolidés : 774,5 M€

View all LES ECHOS COMFI WIRE